Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by CSACI. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CSACI or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Standard Vaccines And Special Cases

28:07
 
Share
 

Manage episode 509327390 series 3514043
Content provided by CSACI. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CSACI or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

“Vaccine counseling is really a team sport. — Dr. Anne Pham-Huy

Vaccines can stir anxiety for patients and confusion for clinicians, especially when biologics enter the mix. Dr. Mariam Hanna is joined by Dr. Anne Pham-Huy, clinical immunologist at CHEO, member of the Special Immunization Clinic Network, NACI member, and chair of Immunize Canada. Together, they break down the science of vaccine responses and tackle some of the trickiest questions allergists face in daily practice.

On this episode:

  • The major types of vaccines — from live attenuated to mRNA — and what sets them apart.
  • Why live vaccines often produce strong, durable protection, but may require caution in certain patients.
  • How adult immunization is still underutilized, with gaps in boosters, pneumococcal, HPV, and influenza coverage.
  • Which “special populations” need tailored vaccine strategies, including patients on immunosuppressants, transplant recipients, and those with chronic disease.
  • Practical guidance on timing vaccines around biologic use and which precautions truly matter.
  • When to check titers and antibody responses — and why it’s only relevant for select patient groups.
  • Strategies for counselling vaccine-hesitant patients with empathy, focusing on disease risk and building trust.
  • What’s next: combination mRNA vaccines and nirsevimab for RSV prevention in infants.

The questions are simple — are they vaccinated, special, or special enough — but the answers matter.

Visit the Canadian Society of Allergy and Clinical Immunology
Find an allergist using our helpful tool
Find Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_ca
The Allergist is produced for CSACI by PodCraft Productions

  continue reading

55 episodes

Artwork
iconShare
 
Manage episode 509327390 series 3514043
Content provided by CSACI. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CSACI or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

“Vaccine counseling is really a team sport. — Dr. Anne Pham-Huy

Vaccines can stir anxiety for patients and confusion for clinicians, especially when biologics enter the mix. Dr. Mariam Hanna is joined by Dr. Anne Pham-Huy, clinical immunologist at CHEO, member of the Special Immunization Clinic Network, NACI member, and chair of Immunize Canada. Together, they break down the science of vaccine responses and tackle some of the trickiest questions allergists face in daily practice.

On this episode:

  • The major types of vaccines — from live attenuated to mRNA — and what sets them apart.
  • Why live vaccines often produce strong, durable protection, but may require caution in certain patients.
  • How adult immunization is still underutilized, with gaps in boosters, pneumococcal, HPV, and influenza coverage.
  • Which “special populations” need tailored vaccine strategies, including patients on immunosuppressants, transplant recipients, and those with chronic disease.
  • Practical guidance on timing vaccines around biologic use and which precautions truly matter.
  • When to check titers and antibody responses — and why it’s only relevant for select patient groups.
  • Strategies for counselling vaccine-hesitant patients with empathy, focusing on disease risk and building trust.
  • What’s next: combination mRNA vaccines and nirsevimab for RSV prevention in infants.

The questions are simple — are they vaccinated, special, or special enough — but the answers matter.

Visit the Canadian Society of Allergy and Clinical Immunology
Find an allergist using our helpful tool
Find Dr. Hanna on X, previously Twitter, @PedsAllergyDoc or CSACI @CSACI_ca
The Allergist is produced for CSACI by PodCraft Productions

  continue reading

55 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play